ASX could prevent lipopolysaccharide-induced acute respiratory distress syndrome (ARDS) and sepsis by suppressing the signaling pathway of MPAK/NF-KB and decreasing pro-inflammatory cytokine level [65]. This evidence concerns the gene NFKB1 and acute respiratory distress syndrome.